Education, industry news, and insights on peptide therapy and regenerative health
Comprehensive analysis of 5+ years of clinical research on GLP-1 peptides (semaglutide, tirzepatide) reveals sustained cardiovascular benefits, manageable side effects, and important long-term safety considerations.
Jun 5, 2026
A comprehensive analysis of peptide bioavailability across delivery methods, comparing oral vs injection absorption rates, exploring barriers to peptide uptake, and reviewing emerging technologies that may transform peptide administration.
May 27, 2026
Examining the current state of BPC-157 human clinical trials, safety data, and evidence gaps between animal research and human applications.
May 23, 2026
Comprehensive analysis of intranasal peptide delivery mechanisms, bioavailability data, clinical applications, and formulation strategies for nasal spray peptide administration.
May 9, 2026
Recent breakthroughs in oral peptide delivery systems are revolutionizing peptide therapy, eliminating the need for injections through advanced technologies like permeation enhancers, nanoparticle encapsulation, and smart delivery devices.
May 7, 2026
TB-500 and BPC-157 are both widely researched healing peptides, but they work through different mechanisms and have different strengths. This comparison breaks down the science behind each, when to use one vs. the other, and whether combining them makes sense.
Mar 17, 2026